Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.
Marco GalluzzoMarina TalamontiLaura AtzoriFederico BardazziCampanati AnnaAntonella Di CesareFederico DiotalleviMaria Laura FloriCristina MughedduAnnamaria OffidaniStefano PiasericoFilomena RussoLidia SacchelliLuca BianchiFrancesca PrignanoPublished in: Expert opinion on biological therapy (2022)
Secukinumab appears to be effective for the treatment of palmoplantar psoriasis also in the real-life setting.
Keyphrases